Enhancement of zidovudine transfer to molt-4 cells, a human t-cell model, by dehydroepiandrosterone sulfate

Tomohiro Nishimura, Jun Tanaka, Masatoshi Tomi, Yoshiaki Seki, Noriko Kose, Yoshimichi Sai, Emi Nakashima

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A possible approach to improve antiretroviral therapy with nucleoside reverse transcriptase inhibitors is to enhance inhibitor delivery to CD4-positive T cells. We previously showed that dehydroepiandrosterone sulfate (DHEAS) enhances zidovudine (AZT) transfer into syncytiotrophoblast. Here, we investigated whether DHEAS also enhances AZT transfer into a cellular model of human T lymphocytes, and whether AZT is taken up by a specific transport system. The effects of DHEAS and related compounds on the uptake of [3H]AZT and other nucleosides by Molt-4 cells (a model of human CD4-positive T cells) were measured. [3H]AZT uptake by Molt-4 cells was nitrobenzylthioinosine insensitive and pH dependent, and the uptake was significantly inhibited by 1 mM ethylisopropylamiloride. [3H]AZT uptake by Molt-4 cells was increased in the presence of DHEAS, whereas uptake of other nucleosides was reduced. Kinetic study revealed that the maximum uptake velocity (up to 30 min) was increased in the presence of DHEAS. The structural requirements for AZT uptake-enhancing activity were studied using structural analogues of DHEAS. Estrone-3-sulfate and 16α-hydroxy DHEAS also enhanced AZT uptake into Molt-4 cells. The use of uptake enhancers may be a good strategy to improve the efficacy of antiretroviral therapy.

Original languageEnglish
Pages (from-to)3959-3967
Number of pages9
JournalJournal of Pharmaceutical Sciences
Volume100
Issue number9
DOIs
Publication statusPublished - 2011 Sep

Fingerprint

Dehydroepiandrosterone Sulfate
Zidovudine
Nucleosides
T-Lymphocytes
Reverse Transcriptase Inhibitors
Trophoblasts
Therapeutics

Keywords

  • Antiretroviral drug
  • AZT
  • Distribution
  • Drug interactions
  • Drug targeting
  • Permeation enhancers
  • Transporter

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Enhancement of zidovudine transfer to molt-4 cells, a human t-cell model, by dehydroepiandrosterone sulfate. / Nishimura, Tomohiro; Tanaka, Jun; Tomi, Masatoshi; Seki, Yoshiaki; Kose, Noriko; Sai, Yoshimichi; Nakashima, Emi.

In: Journal of Pharmaceutical Sciences, Vol. 100, No. 9, 09.2011, p. 3959-3967.

Research output: Contribution to journalArticle

Nishimura, Tomohiro ; Tanaka, Jun ; Tomi, Masatoshi ; Seki, Yoshiaki ; Kose, Noriko ; Sai, Yoshimichi ; Nakashima, Emi. / Enhancement of zidovudine transfer to molt-4 cells, a human t-cell model, by dehydroepiandrosterone sulfate. In: Journal of Pharmaceutical Sciences. 2011 ; Vol. 100, No. 9. pp. 3959-3967.
@article{2d67342c494a4da18eb0df9a1cbd921d,
title = "Enhancement of zidovudine transfer to molt-4 cells, a human t-cell model, by dehydroepiandrosterone sulfate",
abstract = "A possible approach to improve antiretroviral therapy with nucleoside reverse transcriptase inhibitors is to enhance inhibitor delivery to CD4-positive T cells. We previously showed that dehydroepiandrosterone sulfate (DHEAS) enhances zidovudine (AZT) transfer into syncytiotrophoblast. Here, we investigated whether DHEAS also enhances AZT transfer into a cellular model of human T lymphocytes, and whether AZT is taken up by a specific transport system. The effects of DHEAS and related compounds on the uptake of [3H]AZT and other nucleosides by Molt-4 cells (a model of human CD4-positive T cells) were measured. [3H]AZT uptake by Molt-4 cells was nitrobenzylthioinosine insensitive and pH dependent, and the uptake was significantly inhibited by 1 mM ethylisopropylamiloride. [3H]AZT uptake by Molt-4 cells was increased in the presence of DHEAS, whereas uptake of other nucleosides was reduced. Kinetic study revealed that the maximum uptake velocity (up to 30 min) was increased in the presence of DHEAS. The structural requirements for AZT uptake-enhancing activity were studied using structural analogues of DHEAS. Estrone-3-sulfate and 16α-hydroxy DHEAS also enhanced AZT uptake into Molt-4 cells. The use of uptake enhancers may be a good strategy to improve the efficacy of antiretroviral therapy.",
keywords = "Antiretroviral drug, AZT, Distribution, Drug interactions, Drug targeting, Permeation enhancers, Transporter",
author = "Tomohiro Nishimura and Jun Tanaka and Masatoshi Tomi and Yoshiaki Seki and Noriko Kose and Yoshimichi Sai and Emi Nakashima",
year = "2011",
month = "9",
doi = "10.1002/jps.22624",
language = "English",
volume = "100",
pages = "3959--3967",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Enhancement of zidovudine transfer to molt-4 cells, a human t-cell model, by dehydroepiandrosterone sulfate

AU - Nishimura, Tomohiro

AU - Tanaka, Jun

AU - Tomi, Masatoshi

AU - Seki, Yoshiaki

AU - Kose, Noriko

AU - Sai, Yoshimichi

AU - Nakashima, Emi

PY - 2011/9

Y1 - 2011/9

N2 - A possible approach to improve antiretroviral therapy with nucleoside reverse transcriptase inhibitors is to enhance inhibitor delivery to CD4-positive T cells. We previously showed that dehydroepiandrosterone sulfate (DHEAS) enhances zidovudine (AZT) transfer into syncytiotrophoblast. Here, we investigated whether DHEAS also enhances AZT transfer into a cellular model of human T lymphocytes, and whether AZT is taken up by a specific transport system. The effects of DHEAS and related compounds on the uptake of [3H]AZT and other nucleosides by Molt-4 cells (a model of human CD4-positive T cells) were measured. [3H]AZT uptake by Molt-4 cells was nitrobenzylthioinosine insensitive and pH dependent, and the uptake was significantly inhibited by 1 mM ethylisopropylamiloride. [3H]AZT uptake by Molt-4 cells was increased in the presence of DHEAS, whereas uptake of other nucleosides was reduced. Kinetic study revealed that the maximum uptake velocity (up to 30 min) was increased in the presence of DHEAS. The structural requirements for AZT uptake-enhancing activity were studied using structural analogues of DHEAS. Estrone-3-sulfate and 16α-hydroxy DHEAS also enhanced AZT uptake into Molt-4 cells. The use of uptake enhancers may be a good strategy to improve the efficacy of antiretroviral therapy.

AB - A possible approach to improve antiretroviral therapy with nucleoside reverse transcriptase inhibitors is to enhance inhibitor delivery to CD4-positive T cells. We previously showed that dehydroepiandrosterone sulfate (DHEAS) enhances zidovudine (AZT) transfer into syncytiotrophoblast. Here, we investigated whether DHEAS also enhances AZT transfer into a cellular model of human T lymphocytes, and whether AZT is taken up by a specific transport system. The effects of DHEAS and related compounds on the uptake of [3H]AZT and other nucleosides by Molt-4 cells (a model of human CD4-positive T cells) were measured. [3H]AZT uptake by Molt-4 cells was nitrobenzylthioinosine insensitive and pH dependent, and the uptake was significantly inhibited by 1 mM ethylisopropylamiloride. [3H]AZT uptake by Molt-4 cells was increased in the presence of DHEAS, whereas uptake of other nucleosides was reduced. Kinetic study revealed that the maximum uptake velocity (up to 30 min) was increased in the presence of DHEAS. The structural requirements for AZT uptake-enhancing activity were studied using structural analogues of DHEAS. Estrone-3-sulfate and 16α-hydroxy DHEAS also enhanced AZT uptake into Molt-4 cells. The use of uptake enhancers may be a good strategy to improve the efficacy of antiretroviral therapy.

KW - Antiretroviral drug

KW - AZT

KW - Distribution

KW - Drug interactions

KW - Drug targeting

KW - Permeation enhancers

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=79960115024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960115024&partnerID=8YFLogxK

U2 - 10.1002/jps.22624

DO - 10.1002/jps.22624

M3 - Article

VL - 100

SP - 3959

EP - 3967

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 9

ER -